DE69115313D1 - 3-Tetrazolylthiomethyl-Cephalosporin-Antibiotika - Google Patents

3-Tetrazolylthiomethyl-Cephalosporin-Antibiotika

Info

Publication number
DE69115313D1
DE69115313D1 DE69115313T DE69115313T DE69115313D1 DE 69115313 D1 DE69115313 D1 DE 69115313D1 DE 69115313 T DE69115313 T DE 69115313T DE 69115313 T DE69115313 T DE 69115313T DE 69115313 D1 DE69115313 D1 DE 69115313D1
Authority
DE
Germany
Prior art keywords
tetrazolylthiomethyl
cephalosporin antibiotics
cephalosporin
antibiotics
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69115313T
Other languages
English (en)
Other versions
DE69115313T2 (de
Inventor
Frederick Henri Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Original Assignee
Zeneca Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA filed Critical Zeneca Pharma SA
Publication of DE69115313D1 publication Critical patent/DE69115313D1/de
Application granted granted Critical
Publication of DE69115313T2 publication Critical patent/DE69115313T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
DE69115313T 1990-03-16 1991-03-07 3-Tetrazolylthiomethyl-Cephalosporin-Antibiotika Expired - Fee Related DE69115313T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400724 1990-03-16

Publications (2)

Publication Number Publication Date
DE69115313D1 true DE69115313D1 (de) 1996-01-25
DE69115313T2 DE69115313T2 (de) 1996-05-02

Family

ID=8205690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115313T Expired - Fee Related DE69115313T2 (de) 1990-03-16 1991-03-07 3-Tetrazolylthiomethyl-Cephalosporin-Antibiotika

Country Status (16)

Country Link
US (1) US5200404A (de)
EP (1) EP0447118B1 (de)
JP (1) JPH05247058A (de)
KR (1) KR910016762A (de)
AT (1) ATE131484T1 (de)
AU (1) AU638556B2 (de)
CA (1) CA2038411A1 (de)
DE (1) DE69115313T2 (de)
FI (1) FI911286A (de)
GB (1) GB9104238D0 (de)
IE (1) IE910711A1 (de)
IL (1) IL97439A0 (de)
NO (1) NO911041L (de)
NZ (1) NZ237351A (de)
PT (1) PT97044A (de)
ZA (1) ZA911657B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
JPH11124384A (ja) * 1997-10-17 1999-05-11 Otsuka Chem Co Ltd ３−セフェム化合物の製造法
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5133416B2 (ja) 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． １’，３’−二置換−４−フェニル−３，４，５，６−テトラヒドロ−２ｈ，１’ｈ−［１，４’］ビピリジニル−２’−オン
ATE516272T1 (de) 2007-09-14 2011-07-15 Ortho Mcneil Janssen Pharm 1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5852665B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
BR112016016390B1 (pt) 2014-01-21 2023-04-11 Janssen Pharmaceutica Nv Produto compreendendo modulador alostérico positivo do receptor glutamatérgico metabotrópico do subtipo 2 e ligante da proteína de vesícula sináptica 2a
ES2860298T3 (es) 2014-01-21 2021-10-04 Janssen Pharmaceutica Nv Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433141A (en) * 1972-07-07 1976-04-22 Glaxo Lab Ltd Antibiotics
US4024134A (en) * 1971-01-29 1977-05-17 Glaxo Laboratories Limited Syn isomers of cephalosporins having α-hydroximino- or α-acyloxyiminoacylamido groups at position-7
US3926957A (en) * 1971-01-29 1975-12-16 Glaxo Lab Ltd Penicillin antibiotics
US3991046A (en) * 1972-07-07 1976-11-09 Glaxo Laboratories Limited Penicillin antibiotics
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
DE2716677C2 (de) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
EP0272827A3 (de) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-Heterocyclethiomethyl-cephalosporine

Also Published As

Publication number Publication date
JPH05247058A (ja) 1993-09-24
AU7263991A (en) 1991-09-19
EP0447118A2 (de) 1991-09-18
FI911286A0 (fi) 1991-03-15
ZA911657B (en) 1991-11-27
NZ237351A (en) 1992-12-23
IL97439A0 (en) 1992-06-21
US5200404A (en) 1993-04-06
ATE131484T1 (de) 1995-12-15
CA2038411A1 (en) 1991-09-17
EP0447118A3 (en) 1992-06-03
EP0447118B1 (de) 1995-12-13
GB9104238D0 (en) 1991-04-17
IE910711A1 (en) 1991-09-25
PT97044A (pt) 1991-10-31
NO911041D0 (no) 1991-03-15
NO911041L (no) 1991-09-17
KR910016762A (ko) 1991-11-05
FI911286A (fi) 1991-09-17
DE69115313T2 (de) 1996-05-02
AU638556B2 (en) 1993-07-01

Similar Documents

Publication Publication Date Title
ATE131484T1 (de) 3-tetrazolylthiomethyl-cephalosporin-antibiotik
SE7704739L (sv) Antibacterial agents
AU6889294A (en) Novel intermediates useful in the preparation of heteroaroyl derivatives of monocyclic beta-lactam antibiotics
ATE170861T1 (de) Antibiotische carbapenemderivate
DE69212267D1 (de) Echinocandin-B-Derivat
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
FI830192L (fi) Foerfarande foer framstaellning av penicillinderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee